[Complications of verospirone therapy].
I N
IN
Bokarev
N V
NV
Baranova
D000293:Adolescent; D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004415:Dyspepsia / Q000139:chemically induced; D005260:Female; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*; D013997:Time Factors; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D013148:Spironolactone
Oslozhneniia terapii veroshpironom.